From the December 2014 issue of HealthCare Business News magazine


Mary K. Gospodarowicz, MD, FASTRO
Gospodarowicz is a radiation oncologist and the medical director at Princess Margaret Cancer Centre in Toronto, regional vice president of Cancer Care Ontario and a 33-year ASTRO member.

Gospodarowicz’s research has focused on radiation therapy for lymphomas and genitourinary cancers, including prostate cancer, bladder cancer, and seminoma, as well as studies of secondary cancers and other late effects of treatment. She has published numerous seminal papers on the risk of secondary cancers following radiation therapy and chemotherapy for Hodgkin and non-Hodgkin lymphomas, and seminoma. Gospodarowicz and her colleagues at the Princess Margaret Cancer Centre pioneered systematic studies of surveillance in place of routine use of abdominal and thoracic radiation for early-stage seminoma. This change has helped reduce the risk of these patients developing complications and the risk of secondary cancer.
In addition to her research, Gospodarowicz’s more recent work has focused on global health and the role of radiation therapy in treating cancer patients worldwide. She is currently the president of the Union for International Cancer Control , an international organization dedicated to helping reduce the worldwide cancer burden, promote greater equity in cancer control, and place cancer on the global health and development agenda. In this role, Gospodarowicz created the Global Task Force on Radiotherapy for Cancer Control to determine what it would take to close the gap between what exists today and equitable access to radiotherapy for cancer globally.

Throughout her career, Gospodarowicz has mentored trainees and young professionals in the field, emphasizing both clinical and leadership skills. She has also helped develop research master’s and doctoral tracks for radiation therapists within the University of Toronto’s Department of Radiation Oncology.


Leonard L. Gunderson, MD, MS, FASTRO
As a 38-year ASTRO member and former Chair of ASTRO’s Board of Directors, Gunderson has made significant contributions to radiation oncology through research and clinical practice in gastrointestinal cancers, as well as service to ASTRO through his dedication to numerous committees and his nine years serving on ASTRO’s Board of Directors.

December 2014 Magazine

Read more stories from the December 2014 issue

Primary Care Homepage